Asitri Dashboard
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 31
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT01940991 | Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines | ||
NCT06133491 | Open Label, 6-month Study for High Frequency and Chronic Migraine, | ||
NCT01818076 | Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines | ||
NCT03617367 | Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS) | ||
NCT02973269 | DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis | ||
NCT01124565 | Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults | ||
NCT03004248 | Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines | ||
NCT04259086 | Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines | ||
NCT03014622 | Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines | ||
NCT03014635 | Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines | ||
NCT04846530 | Teosyal RHA® Histology and Intradermal Implantation Evaluation Study | ||
NCT00888914 | Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines | ||
NCT02706795 | Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia | ||
NCT00968825 | Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines | ||
NCT00884234 | Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines | ||
NCT01064518 | Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults | ||
NCT03911102 | Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines | ||
NCT06411002 | Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines | ||
NCT03821402 | Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity | ||
NCT02303002 | Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines | ||
NCT00968942 | Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines | ||
NCT02580370 | Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines | ||
NCT02565732 | Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis | ||
NCT01776606 | Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines | ||
NCT03825315 | DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis | ||
NCT01124552 | A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults | ||
NCT03137407 | Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis | ||
NCT03608397 | Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) | ||
NCT06154070 | An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention | ||
NCT03786770 | Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis) | ||
NCT00907387 | Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines |